Yun Xue

6PUBLICATIONS
81CO-AUTHORS
Nuclear physicsPredictive and prognostic markersLiquid biopsiesMolecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 15, 2025
Author Correction: PPIA dictates NRF2 stability to promote lung cancer progression.

Weiqiang Lu, Jiayan Cui, Wanyan Wang

|Jun 03, 2024
PPIA dictates NRF2 stability to promote lung cancer progression.

Weiqiang Lu, Jiayan Cui, Wanyan Wang

|May 28, 2024
TET2-STAT3-CXCL5 nexus promotes neutrophil lipid transfer to fuel lung adeno-to-squamous transition.

Yun Xue, Yuting Chen, Sijia Sun

|Jan 29, 2024
EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation.

Zhen Qin, Meiting Yue, Shijie Tang

|Nov 04, 2023
Selective activator of human ClpP triggers cell cycle arrest to inhibit lung squamous cell carcinoma.

Lin-Lin Zhou, Tao Zhang, Yun Xue

|May 03, 2023
In vivo metabolomics identifies CD38 as an emergent vulnerability in LKB1 -mutant lung cancer.

Jiehui Deng, David H Peng, David Fenyo

Pageof 1